biomedical advanced research and development authority

$590m to Moderna from HHS for mRNA ‘flu vax development

"$590m to Moderna from HHS for mRNA ‘flu vax development" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

Business Insider · 4d

Moderna confirms $590M award by U.S. for bird flu vaccine development

Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of

ABC · 4d

Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

Barron's · 4d

US Health Dept Providing Moderna $590 Mn To Speed MRNA Bird Flu Vaccine

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.

Business Insider · 4d

U.S. Awards $590 Mln To Moderna For MRNA Pandemic Influenza Vaccine Development

The U.S. Department of Health and Human Services or HHS said it will provide approximately $590 million to Moderna (MRNA) to

Yahoo · 4d

As bird flu concerns grow, scientists race to develop new vaccines

As fears grow of a possible bird flu pandemic in humans, the federal government is pouring more money into the development of new vaccines, including an mRNA shot.

22hon MSN

Emergent BioSolutions stock reaffirms buy rating on contract modification

H.C. Wainwright & Co. reaffirmed its Buy rating and $15.00 price target for Emergent BioSolutions stock (NYSE:EBS). The ...

TipRanks on MSN5d

Shionogi Secures BARDA Funding for Long-Acting COVID-19 Antiviral Development

Shionogi & Co. has been awarded a $375 million project agreement by the Biomedical Advanced Research and Development ...

cidrap.umn4d

BARDA to fund development of COVID preventive drug

Shionogi will receive $375 million to develop a long-acting protease inhibitor designed to prevent SARS-CoV-2 infection in ...

The Bakersfield Californian8d

UPDATE - Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode ...

today announced the company won the Biomedical Advanced Research and Development Authority (BARDA) Patch Forward competition and presented at an event during the J.P. Morgan Healthcare Conference ...

Business Wire8d

Vaxxas Named Stage Winner of United States’ BARDA Prize to Advance Microarray Patches for Vaccination

Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, has been named a C ...

Emergent BioSolutions receives contract option valued at $16.7M

Emergent BioSolutions (EBS) announced that the Biomedical Advanced Research and Development Authority executed a contract modification for the ...

Moderna Announces Updates on Pandemic Influenza Program

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...

Yahoo Finance4d

BioNet Wins BARDA Patch Forward Prize for Microneedle mRNA Vaccine Innovation

proudly announces its selection as a Concept Stage winner in the prestigious United States Biomedical Advanced Research and Development Authority (BARDA) Patch Forward Prize. Achieved in ...

The Bakersfield Californian9d

Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results